• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 皮肤表现的最新进展:特殊人群。

Update in cutaneous manifestations of COVID-19: Special populations.

机构信息

Complex Medical Dermatology Fellow, Department of Dermatology, Cleveland Clinic, Cleveland, OH.

Resident Physician, Department of Pediatrics, Cleveland Clinic, Cleveland, OH.

出版信息

Cleve Clin J Med. 2023 Jan 3;90(1):43-52. doi: 10.3949/ccjm.90a.22013.

DOI:10.3949/ccjm.90a.22013
PMID:36596595
Abstract

Cutaneous abnormalities were among the first clinical findings reported in patients infected with SARS-CoV-2 at the onset of the COVID-19 pandemic, but the significance was initially unclear. Correlations have since been drawn between many of these cutaneous eruptions and their diagnostic or prognostic value. Additionally, COVID-19 vaccines have generated acute and delayed cutaneous reactions with which clinicians should be familiar. In this narrative review, we update the cutaneous abnormalities associated with COVID-19 infection for pediatric and non-White populations, and common cutaneous reactions to COVID-19 vaccines.

摘要

皮肤异常是 COVID-19 大流行期间感染 SARS-CoV-2 的患者最初报告的临床发现之一,但最初意义尚不清楚。此后,人们已经发现许多这些皮肤出疹与它们的诊断或预后价值有关。此外,COVID-19 疫苗引起了急性和迟发性皮肤反应,临床医生应该熟悉这些反应。在这篇叙述性综述中,我们更新了与 COVID-19 感染相关的儿科和非白人群的皮肤异常以及 COVID-19 疫苗常见的皮肤反应。

相似文献

1
Update in cutaneous manifestations of COVID-19: Special populations.COVID-19 皮肤表现的最新进展:特殊人群。
Cleve Clin J Med. 2023 Jan 3;90(1):43-52. doi: 10.3949/ccjm.90a.22013.
2
Cutaneous manifestations of COVID-19 patients in a Hospital in São Paulo, Brazil, and global literature review.巴西圣保罗一家医院的 COVID-19 患者的皮肤表现,以及全球文献回顾。
An Bras Dermatol. 2023 Jul-Aug;98(4):466-471. doi: 10.1016/j.abd.2022.09.007. Epub 2023 Mar 10.
3
Skin Diseases Associated With COVID-19: A Narrative Review.与 COVID-19 相关的皮肤疾病:一篇叙述性综述。
Cutis. 2023 Apr;111(4):E19-E27. doi: 10.12788/cutis.0757.
4
Cutaneous signs in COVID-19 patients: A review.COVID-19 患者的皮肤表现:综述。
Dermatol Ther. 2020 Sep;33(5):e13549. doi: 10.1111/dth.13549. Epub 2020 May 29.
5
SARS-CoV-2 vaccine-related cutaneous manifestations: a systematic review.SARS-CoV-2 疫苗相关皮肤表现:系统综述。
Int J Dermatol. 2022 Oct;61(10):1187-1204. doi: 10.1111/ijd.16063. Epub 2022 Feb 9.
6
Clinical and histopathological views of morbilliform rash after COVID-19 mRNA vaccination mimic those in SARS-CoV-2 virus infection-associated cutaneous manifestations.新型冠状病毒肺炎(COVID-19)信使核糖核酸(mRNA)疫苗接种后麻疹样皮疹的临床和组织病理学表现与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒感染相关的皮肤表现相似。
J Dermatol Sci. 2021 Aug;103(2):124-127. doi: 10.1016/j.jdermsci.2021.06.006. Epub 2021 Jun 11.
7
Cutaneous manifestations of SARS-CoV-2 infection during the Delta and Omicron waves in 348 691 UK users of the UK ZOE COVID Study app.英国 ZOE COVID 研究应用程序 348691 名用户中德尔塔和奥密克戎变异株流行期间的 SARS-CoV-2 感染的皮肤表现。
Br J Dermatol. 2022 Dec;187(6):900-908. doi: 10.1111/bjd.21784. Epub 2022 Oct 10.
8
Cutaneous manifestations of the COVID-19 pandemic in schoolchildren and adolescents.儿童和青少年中 COVID-19 大流行的皮肤表现。
Acta Dermatovenerol Alp Pannonica Adriat. 2023 Dec;32(4):173-181.
9
Pityriasis Rosea Associated With COVID-19 Vaccination: A Common Rash Following Administration of a Novel Vaccine.玫瑰糠疹与 COVID-19 疫苗接种相关:新型疫苗接种后常见的皮疹。
Cutis. 2021 Dec;108(6):317-318. doi: 10.12788/cutis.0411.
10
Pityriasis rosea, pityriasis rosea-like eruptions, and herpes zoster in the setting of COVID-19 and COVID-19 vaccination.COVID-19 及 COVID-19 疫苗接种背景下的玫瑰糠疹、玫瑰糠疹样发疹和带状疱疹。
Clin Dermatol. 2022 Sep-Oct;40(5):586-590. doi: 10.1016/j.clindermatol.2022.01.002. Epub 2022 Jan 31.

引用本文的文献

1
Cutaneous Manifestations of COVID-19: A Descriptive Analysis of a Southeastern USA Purposive Sample.新型冠状病毒肺炎的皮肤表现:对美国东南部一个有目的样本的描述性分析
Int Wound J. 2025 Apr;22(4):e70193. doi: 10.1111/iwj.70193.